Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Having Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention?

NCT04436978 is registered in ClinicalTrials.gov with St. Antonius Hospital as lead sponsor.

NCT NCT04436978
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04436978 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Having Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention?
Lead sponsor
St. Antonius Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
January 11, 2023
Completion date
December 1, 2027
Enrollment
2,000 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, atrial fibrillation, atrial flutter, bleeding, coronary artery disease, embolism, myocardial infarction, nstemi - non-st segment elevation mi, stemi - st elevation myocardial infarction, stent thrombosis, stroke